Cost-effectiveness analysis of monthly zoledronic acid, zoledronic acid every 3 months, and monthly denosumab in women with breast cancer and skeletal metastases: CALGB 70604 (Alliance)

Charles L. Shapiro, James P. Moriarty, Stacie Dusetzina, Andrew L. Himelstein, Jared C. Foster, Stephen S. Grubbs, Paul J. Novotny, Bijan J. Borah

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint Dive into the research topics of 'Cost-effectiveness analysis of monthly zoledronic acid, zoledronic acid every 3 months, and monthly denosumab in women with breast cancer and skeletal metastases: CALGB 70604 (Alliance)'. Together they form a unique fingerprint.

Medicine & Life Sciences